BCL2 and gastric cancer: In gastric cancer cells, malvidin promotes an increase in Bax/Bcl-2 ratio, caspase-3 activation, and p38 kinase expression while reducing the ΔΨm and inducing cell cycle blockage at the G0/G1 stage [157].